Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Chevron

Pfizer

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

Exxon Mobil

Experienced dividend investors know that sometimes a high yield is a red flag.

6 Dow Stocks With Yields of 4%+

Walgreens products are also available on Postmates.

DoorDash now delivers over-the-counter medicine from Walgreens

It's only available in three metro regions for now.

Walgreens and DoorDash Teaming up for Delivery Service

CVS Health

Target

Target Corp, CVS Health Corp and Walgreens Boots Alliance Inc said on Thursday they would require customers wear face coverings while shopping at their U.S. stores, adopting a widely accepted way to curb the spread of the coronavirus.

Target, CVS, Walgreens to require customers wear masks at U.S. stores

DEERFIELD, Ill.--(BUSINESS WIRE)-- #Cornavirus--As growing numbers of health officials, including the Centers for Disease Control and Prevention (CDC), are now urging everyone across the U.S.

Walgreens to Require Face Covers at All Stores Chainwide

DoorDash COO Christopher Payne told CNBC that the company's strategy to grow expand outside restaurant delivery was influenced by the coronavirus pandemic.

DoorDash partners with Walgreens to deliver over-the-counter drugs and other health products

SAN FRANCISCO & DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens and DoorDash Announce On-Demand Delivery Collaboration

Walgreens and DoorDash Announce On-Demand Delivery Collaboration

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens has been recognized for the fourth consecutive year with a top score of 100 percent on the 2020 Disability Equality Index® (DEI), a joint initiative by Disability:IN and the American Association of People with Disabilities (AAPD).

Walgreens Earns Best Place to Work on 2020 Disability Equality Index

Dominion Energy

Duke Energy

Lowe's

Dividend Changes: July 4-10, 2020

Despite A Dismal Quarter, It's Nearly Time To Buy Walgreens

Walgreens: Shunned By The Market - Why I See An Opportunity

The shortfall and dramatic performance in the UK illustrates just how much further COVID-19 stress could hurt the company.

Walgreens - Too Soft, Cheap But No Triggers

Aflac

Cisco Systems

Con Ed

Johnson & Johnson

Tyson Foods

Unilever

Dividend Stock Purchase: Lanny's June 2020 Summary

Before the market opened on July 9, Walgreens Boots Alliance Inc. (NASDAQ:WBA) announced its earnings results for its third quarter of fiscal 2020, which ended on May 31.

Walgreens: Recovering With the People, Not the Economy

Advanced Micro Devices

Roku

Virgin Galactic

Best Buy

Roku, Virgin Galactic, Advanced Micro Devices, Walgreens and Bed Bath & Beyond were our top stock trades from Thursday.
The post 5 Top Stock Trades for Friday: ROKU, AMD, SPCE, WBA, BBBY appeared first on InvestorPlace.

5 Top Stock Trades for Friday: ROKU, AMD, SPCE, WBA, BBBY

Microsoft

Walgreens is raising its cost savings target as the pandemic hits sales and profits, and analysts see Microsoft and Cisco as good bets.

Dow Jones Drops 300 Points as Walgreens' Profits Plunge, Microsoft and Cisco Stocks Upgraded

Walgreens Boots Alliance Inc. (NASDAQ: WBA) slid on Thursday after the company reported its fiscal third-quarter financial results.

It’s More Than Earnings Holding Back Walgreens

Walgreens Boots Alliance, Inc. (WBA) CEO Stefano Pessina on Q3 2020 Results - Earnings Call Transcript

Walgreens Boots' (WBA) fiscal third-quarter results reflect overall top line improvement despite COVID-19-led business disruptions.

Walgreens Boots (WBA) Q3 Earnings Lag Estimates, Margin Down

Bed Bath & Beyond

A steep descent came after more bad news on the employment front.

Stock Markets Fall Sharply Thursday Morning as Weak Earnings Hit Bed Bath & Beyond, Walgreens Hard

ConocoPhillips

MetLife

Phillips 66

Daily Dividend Report: Walgreens Boots Alliance, CSX, Conoco Phillips, MetLife, Phillips 66

Why Walgreens' Earnings Plunged in Q3

Walgreens earnings on Thursday has WBA stock down after the company reported mixed figures for third quarter of fiscal year 2020.
The post Walgreens Earnings: WBA Stock Plummets 9% on Mixed Q3 Results appeared first on InvestorPlace.

Walgreens Earnings: WBA Stock Plummets 9% on Mixed Q3 Results

Walgreens is laying off 4,000 employees at Boots, its United Kingdom drugstore division.

Walgreens to cut 4,000 jobs at its UK Boots division

Walgreens Boots Alliance (NASDAQ: WBA) published its quarterly financial results on Thursday that acknowledged a significant hit from COVID-19 that minimised visits to the doctor and slashed demand for medicines in recent months. The company also spent more on cleaning stores and keeping its staff on payroll amidst the outbreak.

News for Walgreens Stock (WBA)